ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $706,000 | -14.3% | 961,460 | +8.9% | 0.00% | 0.0% |
| Q1 2020 | $824,000 | -70.5% | 883,253 | -35.6% | 0.00% | -66.7% |
| Q4 2019 | $2,797,000 | +44.0% | 1,371,236 | +102.6% | 0.00% | +50.0% |
| Q3 2019 | $1,943,000 | +6.9% | 676,843 | +185.7% | 0.00% | 0.0% |
| Q2 2019 | $1,817,000 | -51.3% | 236,927 | -15.5% | 0.00% | -50.0% |
| Q1 2019 | $3,728,000 | +43.8% | 280,486 | +68.6% | 0.00% | +33.3% |
| Q4 2018 | $2,592,000 | +8.6% | 166,349 | +36.9% | 0.00% | +50.0% |
| Q3 2018 | $2,386,000 | +267.1% | 121,471 | +436.3% | 0.00% | +100.0% |
| Q2 2018 | $650,000 | -65.0% | 22,649 | -71.2% | 0.00% | -50.0% |
| Q1 2018 | $1,858,000 | -77.8% | 78,575 | -79.9% | 0.00% | -77.8% |
| Q4 2017 | $8,381,000 | +52.2% | 390,717 | +67.8% | 0.01% | +28.6% |
| Q3 2017 | $5,506,000 | +23.6% | 232,810 | +3.0% | 0.01% | +16.7% |
| Q2 2017 | $4,453,000 | +63.8% | 226,037 | +74.6% | 0.01% | +50.0% |
| Q1 2017 | $2,719,000 | +65.6% | 129,458 | +48.3% | 0.00% | +100.0% |
| Q4 2016 | $1,642,000 | -0.7% | 87,304 | +10.2% | 0.00% | -33.3% |
| Q3 2016 | $1,654,000 | -11.4% | 79,241 | +8.3% | 0.00% | 0.0% |
| Q2 2016 | $1,866,000 | +52.0% | 73,151 | +57.5% | 0.00% | +50.0% |
| Q1 2016 | $1,228,000 | -30.9% | 46,439 | -12.9% | 0.00% | -50.0% |
| Q2 2015 | $1,776,000 | -48.3% | 53,306 | -48.4% | 0.00% | -50.0% |
| Q1 2015 | $3,436,000 | +4.9% | 103,237 | +28.8% | 0.01% | +14.3% |
| Q4 2014 | $3,276,000 | +98.4% | 80,164 | +64.5% | 0.01% | +40.0% |
| Q3 2014 | $1,651,000 | -17.4% | 48,720 | -17.9% | 0.01% | 0.0% |
| Q2 2014 | $2,000,000 | -6.8% | 59,320 | +4.8% | 0.01% | -16.7% |
| Q1 2014 | $2,146,000 | +54.4% | 56,609 | +18.9% | 0.01% | +50.0% |
| Q4 2013 | $1,390,000 | -34.2% | 47,609 | -22.7% | 0.00% | -42.9% |
| Q3 2013 | $2,112,000 | +112.7% | 61,609 | +104.6% | 0.01% | +75.0% |
| Q2 2013 | $993,000 | – | 30,109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |